Lung cancer
Conditions
Interventions
Control Group:Chemotherapy
Sponsors
Hubei Cancer Hospital
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. The patients voluntarily joined the study, signed the informed consent form, and had good compliance. 2. Patients diagnosed with lung cancer according to imaging, cytology and histological examinations; patients diagnosed with lung cancer in stages IIIB-IV according to the 8th edition of the International Union Against Cancer (UICC) revised TNM staging. 3. Patients who are or will be receiving platinum-based chemotherapy. 4. Estimated survival > 3 months. 5. KPS score > 60 points. 6. Aged >= 18 years.
Exclusion criteria
Exclusion criteria: 1. Those with other active malignant tumors or those who have not recovered from other major operations before; 2. There are factors that obviously affect the absorption of oral drugs, such as inability to swallow, chronic diarrhea and intestinal obstruction; 3. Complicated with severe infection or confirmed to have other major physiological dysfunction; 4. Patients with serious diseases such as the heart, liver, kidney, hematopoietic system, as well as those with severe functional impairment, and mentally ill patients; 5. Pregnant and lactating patients; 6. Those who cannot cooperate with the treatment; 7. Allergic constitution, history of allergy to chrysanthemum, licorice, or history of severe food or drug allergy.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Quality of life;Chemotherapy-related adverse reactions; | — |
Secondary
| Measure | Time frame |
|---|---|
| Karnofsky score;Weight; | — |
Countries
China
Contacts
Public ContactWang Jun
Hubei Cancer Hospital
Outcome results
None listed